Published on in Vol 5, No 4 (2019): Oct-Dec
Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12016, first published .
Human Vaccines & Immunotherapeutics
|Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives|
|Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season|
Advances in Therapy
|Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis|